In this article, we analyze the role of innovation and technology policy in concepts of modern industrial policy and … present current insights about its successful integration. The systemic innovation policy contributes substantially to the … principles for public policy and the higher diversification of policy tools. Past examples of biotechnology in the US and the …

Through our historical analysis of the evolution of biotechnology, we show that highly varied understandings of the … value embodied in biotechnology existed. Across three eras (1973-1986 and 1988-2000 and 2003-present), entrepreneurs … constructed different economic logics for biotechnology, often in highly contested settings against multiple entrepreneurial …

knowledge are generated by firms. Ties in the home region are predicted to provide a platform for technological innovation and … literature by 119 biotechnology firms. The papers involve collaboration between firm scientists and scientists working in … forward citation streams to the papers: technological innovation is measured as patent-to-paper citations, and research impact …

This paper examines the effect of foreign direct investment (FDI) on domestic innovation based on a data set covering … show that there is a negative horizontal spillover effect of FDI on domestic innovation when the intellectual property … on why developing countries should encourage FDI and strengthen the IPR regime together to enhance domestic innovation …

Asia, have engaged in improving their innovation capability in the economic transition. First, I measured and compared … innovation capability of both countries by using not only various input and output indicators of innovation systems but also the … how both countries developed their innovation capabilities by focusing on their transformation of the national innovation …

We use longitudinal, disease-level data to analyze the impact of pharmaceutical innovation on longevity and medical … expenditure in Sweden, where mean age at death increased by 1.88 years during the period 1997-2010. Pharmaceutical innovation is … the number of drugs to treat a disease, not the number of drug classes. Pharmaceutical innovation also reduced hospital …

Longitudinal, disease-level data are used to analyze the impact of pharmaceutical innovation on longevity (mean age at … pharmaceutical innovation increased mean age at death by 0.87 years (10.4 months) - about 44% of the total increase in longevity … pharmaceutical innovation. The baseline estimate of the cost per life-year gained from pharmaceutical innovation in Greece is $17 …

This paper quantifies the relationship between market size and innovation in the pharmaceutical industry using improved …, and newer, methods and data. We find positive significant elasticities of innovation to expected market size with a point … the cost of innovation of 800 million to one billion per drug, and marginal costs of manufacture and distribution near 50 …

This paper quantifies the relationship between market size and innovation in the pharmaceutical industry. We estimate … the elasticity of innovation, as measured by the number of new chemical entities appearing on the market for a given … the hypothesis that innovation in pharmaceuticals is becoming more difficult and expensive over time, as costs of …